March 9 (Reuters) - TG Therapeutics Inc :
* TG THERAPEUTICS ANNOUNCES PUBLICATION OF RESULTS FROM THE UNITY-NHL PHASE 2B TRIAL EVALUATING UMBRALISIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA IN THE JOURNAL OF CLINICAL ONCOLOGY
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* TG THERAPEUTICS ANNOUNCES PUBLICATION OF RESULTS FROM THE UNITY-NHL PHASE 2B TRIAL EVALUATING UMBRALISIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA IN THE JOURNAL OF CLINICAL ONCOLOGY
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)